254 related articles for article (PubMed ID: 36017915)
1. A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell.
Xu X; Zhang Y; Wang M; Zhang X; Jiang W; Wu S; Ti X
Crit Rev Eukaryot Gene Expr; 2022; 32(8):43-53. PubMed ID: 36017915
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
4. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
Zhang C; Huang J; Lou K; Ouyang H
Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway.
Zhang L; He X; Jin T; Gang L; Jin Z
Biomed Pharmacother; 2017 Dec; 96():884-891. PubMed ID: 29145165
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.
Guo J; Chen Z; Jiang H; Yu Z; Peng J; Xie J; Li Z; Wu W; Cheng Z; Xiao K
Cancer Cell Int; 2019; 19():312. PubMed ID: 31787849
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA DLX6-AS1 is upregulated in preeclampsia and modulates migration and invasion of trophoblasts through the miR-376c/GADD45A axis.
Tan Y; Xiao D; Xu Y; Wang C
Exp Cell Res; 2018 Sep; 370(2):718-724. PubMed ID: 30055134
[TBL] [Abstract][Full Text] [Related]
10. lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/β-catenin signaling pathway.
Lin H; Shangguan Z; Zhu M; Bao L; Zhang Q; Pan S
J Cell Biochem; 2019 Jun; 120(6):10625-10632. PubMed ID: 30697812
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
[TBL] [Abstract][Full Text] [Related]
12. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
Wu C; Lin W; Fu F
Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
16. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt/β-catenin pathway through modulating the miR-657/dickkopf WNT signaling pathway inhibitor 2 axis.
Zhang Y; Yuan J; Guo M; Xiang R; Xie T; Zhuang X; Dai W; Li Q; Lai Q
Biol Direct; 2023 Feb; 18(1):3. PubMed ID: 36747258
[TBL] [Abstract][Full Text] [Related]
18. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.
Cheng Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645
[TBL] [Abstract][Full Text] [Related]
19. Natural Antisense Long Noncoding RNA HHIP-AS1 Suppresses Non-Small-Cell Lung Cancer Progression by Increasing HHIP Stability via Interaction with CELF2.
Yang Y; Cheng Y; Mou Y; Tang X; Mu X
Crit Rev Eukaryot Gene Expr; 2022; 33(1):67-77. PubMed ID: 36374812
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]